Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

A Novel Continuous Glucose Monitoring Enhanced DPP Intervention to Prevent Type 2 Diabetes in Adults With Prediabetes

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• adults aged 18 years or older,

• diagnosis of prediabetes, as defined by current clinical guidelines (HbA1c 5.7% to 6.4%, fasting plasma glucose 100-125 mg/dL, or 2-hour plasma glucose 140-199 mg/dL following a 75g oral glucose tolerance test),

• body mass index (BMI) of at least 24 kg/m² (or 22 kg/m² for Asian Americans),

• willingness to comply with all aspects of the study protocol, including attending coaching sessions and using CGM devices.

Locations
United States
New York
Division of Population Health, Department of Medicine
RECRUITING
Buffalo
Contact Information
Primary
Raphael A Fraser, PhD, MS
rfraser@buffalo.edu
7168295733
Backup
Jocelyn Stooks, MPH
jstooks@buffalo.edu
7168292364
Time Frame
Start Date: 2026-04-13
Estimated Completion Date: 2028-03
Participants
Target number of participants: 214
Treatments
Active_comparator: Control
Diabetes Prevention Program
Experimental: Intervention
Diabetes Prevention Program + Continuous Glucose Monitors/Coaching
Related Therapeutic Areas
Sponsors
Leads: State University of New York at Buffalo

This content was sourced from clinicaltrials.gov